These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 20800815)

  • 1. Questions arising from "the origin and role of MHC class I-associated self-peptides".
    Kasahara M
    Prog Mol Biol Transl Sci; 2010; 92():61; discussion 62-4. PubMed ID: 20800815
    [No Abstract]   [Full Text] [Related]  

  • 2. The origin and role of MHC class I-associated self-peptides.
    Perreault C
    Prog Mol Biol Transl Sci; 2010; 92():41-60. PubMed ID: 20800814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licensing of natural killer cells by self-major histocompatibility complex class I.
    Yokoyama WM; Kim S
    Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.
    Tjoa BA; Kranz DM
    Cancer Res; 1994 Jan; 54(1):204-8. PubMed ID: 7505197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-help in T cell recognition?
    Bakker TR; van der Merwe PA
    Nat Immunol; 2002 Jan; 3(1):11-2. PubMed ID: 11753401
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I.
    Stagsted J
    APMIS Suppl; 1998; 85():1-40. PubMed ID: 9849573
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral decoy vetoes killer cell.
    Kärre K; Welsh RM
    Nature; 1997 Apr; 386(6624):446-7. PubMed ID: 9087399
    [No Abstract]   [Full Text] [Related]  

  • 11. NK cell tolerance: revisiting the central dogma.
    MacDonald HR
    Nat Immunol; 2005 Sep; 6(9):868-9. PubMed ID: 16116465
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
    Engelhard VH; Bullock TN; Colella TA; Mullins DW
    Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking license with natural killer cell maturation and repertoire development.
    Parham P
    Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigens.
    Ordaz ML; Larmonier N; Lybarger L
    Cell Immunol; 2010; 262(2):141-9. PubMed ID: 20199770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
    Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
    Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.